Susquehanna International Group’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-420,511
| Closed | -$4.17M | – | 13748 |
|
|
2023
Q1 | $4.17M | Buy |
420,511
+257,986
| +159% | +$2.56M | ﹤0.01% | 3722 |
|
|
2022
Q4 | $1.62M | Buy |
+162,525
| New | +$1.21M | ﹤0.01% | 5113 |
|
|
2022
Q2 | – | Sell |
-96,094
| Closed | -$454K | – | 14390 |
|
|
2022
Q1 | $581K | Buy |
96,094
+7,025
| +8% | +$42.8K | ﹤0.01% | 8587 |
|
|
2021
Q4 | $751K | Buy |
89,069
+57,651
| +183% | +$504K | ﹤0.01% | 8062 |
|
|
2021
Q3 | $285K | Buy |
+31,418
| New | +$270K | ﹤0.01% | 10721 |
|
|
2016
Q2 | – | Sell |
-320
| Closed | -$5K | – | 9531 |
|
|
2016
Q1 | $5K | Buy |
+320
| New | +$4.45K | ﹤0.01% | 8902 |
|
|
2015
Q2 | – | Sell |
-738
| Closed | -$73K | – | 10576 |
|
|
2015
Q1 | $140K | Buy |
738
+401
| +119% | +$92.1K | ﹤0.01% | 8840 |
|
|
2014
Q4 | $73K | Sell |
337
-126
| -27% | -$28.1K | ﹤0.01% | 9277 |
|
|
2014
Q3 | $126K | Sell |
463
-767
| -62% | -$208K | ﹤0.01% | 8991 |
|
|
2014
Q2 | $376K | Sell |
1,230
-60
| -5% | -$19K | ﹤0.01% | 7997 |
|
|
2014
Q1 | $473K | Buy |
+1,290
| New | +$468K | ﹤0.01% | 6819 |
|
Susquehanna International Group's APEN Position: Q2 2023 in Review
Susquehanna International Group sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 420,511 shares — an estimated $4.17M sold.
Susquehanna International Group first reported a position in APEN in Q1 2014 and held it in 11 quarters. The position peaked at $4.17M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Susquehanna International Group reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Susquehanna International Group sold 420,511 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $4.17M.
- Susquehanna International Group first reported a position in Apollo Endosurgery, Inc. in Q1 2014 and held it in 11 quarters.
- Susquehanna International Group's Apollo Endosurgery, Inc. position peaked at $4.17M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.